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NEUROGENIC CONTROL OF CUTANEOUS FUNCTION 
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Human keratinocytes have the full capacity for the 
biosynthesis and degradation of catecholatnines. En­
zymes in this biosynthetic pathway, as well as those 
involved in the synthesis of the essential co-factor 
(6R)L-erythro-S,6, 7 ,8-tetrahydrobiopterin (6-BH4) 
are expressed in keratinocytes producing the itnpor­
tant hortnones norepinephrine and epinephrine, 
which control a high /32-adrenoceptor density on 
undifferentiated/proliferating keratinocytes and the 
expression of al-adrenoceptors on tnelanocytes. Re­
ceptor nutnbers correlate with calciutn uptake or 
release into the cell cytosol, which influences the 
process of differentiation. After the differentiation 
process, the enzytne activities, co-factors, and /32-
adrenoceptor densities decrease significantly in kera­
tinocytes, suggesting a tnajor function of this signal 
transduction systetn in regulation of calciutn ho­
meostasis in the epidertnis. The itnportance of this 
I n order to study the adrenergic response in the human epidermis, several factors must be considered: (i) the bio­synthesis and degradation of the catecholamines from the essential amino acid L-phenylalanine; (ii) the expression of adrenoceptors on keratinocytes and melanocytes it! llilJO and 
ill l'ilro; (iii) the structure and function of adrenoceptors in the 
epidermis; (iv) the relationship between the adrenergic response 
and other neuronal systems such as the cholinergic signal transduc­
tion pathways; and (v) the consequences of dysfunctional adrener­
gic systems in the pathophysiology of various skin disorders. 
CATECHOLAMINE SYNTHESIS AND DEGRADATION IN 
THE EPIDERMIS 
In 1980, Lewinsohn ct at found that human full-thickness skin 
contained the c atecholarnine-degrading enzyme monoamine oxi­
dase A (MAO-A) (Lewinsohn ('I ai, 1980). A decade later, Elayan ('{ 
al (1990) measured the conversion of norepinephrine to epineph­
rine in rat skin catalyzed by phenylethanolamine-N-methyl trans­
ferase (PNMT) (Elayan ('I ai, 1990). Upon examination of human 
epidermal extracts, as well as extracts fi'om human keratinocytes, 
melanocytes, and tlbroblasts, the key enzyme for catecholamine 
biosynthesis, i.e., tyrosine hydroxylase as well as the presence of 
Reprint requests to: Profesmr K.U. Schallreuter, Clinical and Experimen­
tal Dermatology, Department of Biomedical Sciences, University of Brad­
ford, Bradford BD7 IDP, West Yorkshire, U.K. 
Abbreviations: MAO-A, monoamine oxidase A; PNMT, phenylctha­
nolallline-N-methyl transferase; 6-BH", (6R)L-erythro-S,6, 7 ,8-tetrahydro­
hiopterin. 
systetn has been followed in two distinct skin disor­
ders: (i) vitiligo, and (ii) atopic eczetna. In vitiligo, 
there is an overproduction of 6-BH4 leading to a 
dysregulation of catecholatnine biosynthesis with in­
creased plastna and epidertnal norepinephrine levels 
associated with high nutnbers of /32-adrenoceptors in 
differentiating keratinocytes and with a defective 
calciutn uptake in both keratinocytes and tnelano­
cytes. In atopic eczetna, a point tnutation in the 
/32-adrenoceptor gene could alter the structure and 
function of the receptor, thereby leading to a low 
density of receptors on both keratinocytes and pe­
ripheral blood lytnphocytes. This review sutntnarizes 
adrenoceptor structure and function in nortnal 
healthy epidertnis cotnpared to lesional epidertnis of 
patients with vitiligo or atopic eczetna. Key words: 
catecholamines/adrenoceptors/calcium. Journal of Investiga­
tive Dermatology Symposium Proceedings 2:37-40, 1997 
PNMT has been identitled (Schallreuter el ai, 1992). Activities for 
tyrosine hydroxylase and PNMT in epidermal extracts were com­
parable to those previously reported ill neuronal tissue (Lewinsohn 
el ai, 1980). Only undifferentiated keratinocytes, however, ex­
pressed tyrosine hydroxylase and PNMT at signitIcant levels 
whereas the catecholamine biosynthetic pathway was absent in 
both melanocytes and fibroblasts (Schallreuter et ai, 1992, 1995). 
The presence of TH, PNMT, MAO-A, and the other cate­
cholamine-degrading enzyme, catechol-o-methyl-transferase, were 
contlrmed by immunohistochemical staining of the epidermis with 
monoclonal antibodies to these proteins (LePoole e/ ai, 1994; 
Schallreuter el ai, 1995, 1996a). Very recently, Hyland (1996)1 has 
demonstrated that both epidermal and hair undifferentiated kerati­
nocytes contain mRNAs for TH, two distinct forms for dopa 
decarboxylase and PNMT. The result on dopa decarboxylase is 
very interesting because this enzyme catalyzes both the decarbox­
ylation of L-dopa to dopamine and L-tryptophan to 5-0H 
tryptamine, suggesting that serotonin biosynthesis probably also 
occurs in human keratinocytes. The pathway for catecholamine 
synthesis is presented in Fig 1. 
It has been well established that the synthesis of L-tyrosine from 
L-phenylalanine and the control of L-dopa formation from L­
tyrosine depends on the rate-limiting co-factor/electron donor 
(6R)L-erythro-5,6,7,8-tetrahydrobiopterin (6-BH4) (Rembold and 
1 Hyland K: Abnormalities of biogenic amine metabolism: clinical diag­
nostic and molecular aspects. Alois Niederwieser Memorial Lecture. 9th 
1I1tcmatiollai COllfer{'/1CC 011 Pteridincs. Port Douglas, Australia, May 19-24, 
1996, (abstr) Pteridil1cs (1996) in press. 
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Figure 1_ Pathway for the biosynthesis of the catecholatnines frotn 
L-tyrosine_ Phenylalanine hydroxylase and tyrosine hydroxylase both use 
6-BH4 as a co-factor leading to the synthesis of L-dopa, which is converted 
by the decarboxylase in the presence of pyridoxalphosphatc to dopamine. 
This metabolite is used by dopamine hydroxylase in the presence of 
ascorbate to form norepinephrine. Phenylethanolamine-N-methyl-trans­
ferase catalyzes the reaction to epinephrine in the presence of S-adenosyl­
illethionine. 
Gyure, 1972). This important co-factor is synthesized by undiffer­
entiated keratinocytes and melanocytes. It was shown that 6-BH4 
can control catecholamine biosynthesis in keratinocytes and mela­
nogenesis in melanocytes (Schallreuter et aI, 1994a, 1994b; Wood 
et ai, 1995). All of the enzyme activities and mRNAs for the de flOPO 
synthesis and recycling of 6-BH4 are present in both cel1s. The 
central position of 6-BH. is presented in Fig 2, where the 
rate-limiting enzyme for the de flOPO synthesis of 6-BH4 is GTP 
cyclohydrolase 1. The activity of this enzyme is controlled by the 
concentration of L-phenylalanine in the epidermis and by its own 
metabolic end product 6-BH4 (Harada et ai, 1993). Furthermore, 
GTP-cyclohydrolase I is induced by several cytokines (i.e., tumor 
necrosis factor-a > mast cel1 growth factor > interleukin-2 > 
interferon-y) (Ziegler, 1990; Werner et ai, 1992). Consequently, 
this enzyme plays a central role in the regulation of both catechol­
amine signal transduction and melanogenesis (Schallreuter, 1994a, 
1994b). 
THE EXPRESSION OF ADRENOCEPTORS IN THE 
HUMAN EPIDERMIS 
Gazith (1983) and later Steinkraus et al (1992) and Schal1reuter et al 
(1993) showed that human keratinocytes and split thickness skin 
contain a high density of {32-adrenoceptors with 7,000 receptors/ 
cell. Recently, Schallreuter et al (1996) found that a1-adrenocep­
tors (i.e., 4,000/cell) can be induced on melanocytes by extracel­
lular norepinephrine. The autocrine production of catecholamines 
by keratinocytes can control the expression of {32-adrenoceptors on 
keratinocytes and a1-adrenoceptors on melanocytes, suggesting a 
true symbiotic relationship between these two cell types in the 
epidermal unit. Koizumi et al (1992) were the first to show that 
extracellular catecholamines can regulate calcium homeostasis via 
the {32-adrenoceptor signal in undifferentiated keratinocytes, and 
they suggested a major function for adrenoceptors in the epidermis 
in the control of intracellular calcium levels. 
THE STRUCTURE AND FUNCTION OF 
ADRENOCEPTORS ON KERATINOCYTES AND 
MELANOCYTES 
The action of catecholamines in the epidermis on undifferentiated 
keratinocytes involves the modulation of cAMP and calcium by 
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Figure 2_ The itnportance of L-phenylalanine and 6-BH. for the 
synthesis of the catecholatnines in keratinocytes and tnelanins by 
tnelanocytes. l30th epidermal melanocytes and keratinocytcs have the full 
capacity for de "''''0 synthesis/recycling of 6-BH4• The key enzyme for the 
de "ovo synthesis of 6-BH4 is GTP-cyclohydrolase I. This enzyme is 
controlled by L-phenylalanine (positive feedback) as well as several cyto­
kines (tumor necrosis factor-a, mast cell growth factor, interleukin-2, and 
interferon-y). 6-BH4 is the essential co-factor (a) for phenylalanine hydrox­
ylase to metabolize L-phenylalanine to L-tyrosille, (b) for tyrosine hydrox­
ylase to convert L-tyrosine into L-dopa in the catecholamine biosynthesis in 
keratinocytes, and (c) a regulator of tyrosinase activity in melanocytes, 
where 6-BH4 inhibits the enzyme and the oxidized product 6-biopterin 
releases the activity. The recycling of6-BH4 is catalyzed by the rate-limiting 
4a-hydroxy-BH4 dehydratase via quinonoid dihydropterin (qBH1). If 
6-l3H4 is overproduced, as in vitiligo, then 4a-OH l3H4 is nonenzymatically 
converted to micromolar levels of7-BH4 inhibiting phenylalanine hydrox­
ylase and consequently resulting in decreased L-tyrosine supply. 
binding to membrane-associated {32-adrenoceptors. The {32-adre­
noceptor is a 64-kDa protein that spans the plasma membrane with 
seven trans-membrane-helices acting via a GTP-binding protein 
(G-protein). The G-proteins consist of a, {3, and y subunits that 
remain associated due to GDP binding. If a signal activator such as 
norepinephrine or epinephrine binds to the receptor, the a subunit 
dissociates to activate adenyl cyclase, yielding cAMP with a con­
comitant uptake of calcium to increase the cytosolic concentration 
of this fast exchange ion (Kobilka et ai, 1987). One consequence of 
this cascade of events is keratinocyte differentiation (Schallreuter et 
aI, 1995). After differentiation, the synthesis of the catecholamines 
and the density of {32-adrenoceptors are significantly reduced. For 
melanocytes, the time-dependent induction of a1-adrenoceptors 
has been shown to depend on the extracellular concentration of 
norepinephrine (Schallreuter et ai, 1996b). This signal transduction 
system activates the diacylglycerol/protein kinase C cascade with 
inosine triphosphate (IP 3) causing an increase in intracellular cal­
cium in the cytosol from intracellular stores present in the endo­
plasmic reticulum. Differentiation of melanocytes ensues followed 
by the onset of melanogenesis (Park et ai, 1993). Therefore, 
catecholamines produced by undifferentiated keratinocytes can 
control melanocyte growth, differentiation, and pigmentation 
(Schallreuter et ai, 1996a). Clearly, calcium homeostasis is a central 
function of the adrenergic systems in the epidermis, as first 
suggested by Koizumi et al (1993). 
THE RELATIONSHIP BETWEEN THE ADRENERGIC AND 
CHOLINERGIC SYSTEMS IN THE EPIDERMIS 
Grando et al (1995) found that undifferentiated human keratino­
cytes have the capacity for the synthesis and degradation of 
acetylcholine and express muscarinic receptors. On the other hand, 
differentiated keratinocytes primarily express nicotinic receptors 
(Grando et ai, 1996). The muscarinic receptors favor calcium efflux 
from undifferentiated keratinocytes to promote both cell growth 
and migration; meanwhile, the nicotinic receptors increase uptake 
of calcium to ensure differentiation, maintaining the calcium gra-
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dient in the epidermis (Menon et ai, 1985). As in neuronal tissue, it 
appears that adrenergic and cholinergic receptors act synergistically 
in the epidermis for the maintenance of calcium homeostasis 
(Gran do et aI, 1995, 1996; Grando, 1997). 
EXAMPLES OF ADRENERGIC DYSFUNCTION IN THE 
SKIN DISORDERS VITILIGO AND ATOPIC ECZEMA 
Vitiligo In the depigmentation disorder vitiligo, there is an 
overproduction of 6-BH4 in both lesional and non Ie siona I epider­
mis (Schallreuter et aI, 1994a, 1994b). The increased de 1101'0 
synthesis of 6-BH4 is caused by a significant activation of GTP­
cyclohydrolase 1. In addition, 6-BH'1 cannot be efficiently recycled 
by 4a-hydroxy-6-BH4-dehydratase and consequently, the nonen­
zymatic isomer 7-BH4 accumulates in the epidermis in micromolar 
concentrations. These concentrations of 7-BH4 can inhibit phenyl­
alanine hydroxylase, thus preventing the synthesis of L-tyrosine 
from L-phenylalanine. 7-BH4 can also inhibit tyrosinase directly by 
an uncompetitive mechanism to stop melanogenesis in melanocytes 
(Wood ct aI, 1995). Excess 6-BH4 is oxidized to 6-biopterin, which 
accumulates in lesional skin, and it has been shown that it is 
cytotoxic to melanocytes under ill I'itro conditions (Schallrcuter ef 
ai, 1995). On the other hand, it was demonstrated that micromolar 
concentrations of 6-BH4 upregulate tyrosine hydroxylase by an 
allosteric mechanism (Naoi et aI, 1993). The high levels of 6-BH4 in 
patients with vitiligo would be in agreement with an increase of 
catecholamines in the epidermis and in plasma of these patients 
followed by an induction of {32-adrenoceptors on keratinocytes 
(Schallreuter cf ai, 1995). Both MAO-A and catechol-o-methyl­
transferase activities arc induced (Schallreuter et ai, 1996a; LePoole 
cf aI, 1994). Increased 7-BH4 production leads to inhibition of 
phenylalanine hydroxylase with concomitant production of H20z 
(Schallreuter ef aI, 1994). H20z is also a product of MAO-A 
activity. High levels of HZ02 can inactivate catalase and oxidize 
6-BH4 (Aronoff, 1965; Armarego, 1984) Low catalase levels in the 
epidermis of this patient group correlate with these findings 
(Schallreuter ef aI, 1991). 
Atopic Eczema As early as 1968, the {3-blockade theory of 
atopy had been proposed (Szentivanyi, 1968). In addition to low 
�2-adrenoceptor binding on lymphocytes, an overstimulation of 
cAMP synthesis in leucocytes correlates with increased phosphodi­
esterase activities in these patients (Pochet et ai, 1980; Chan et ai, 
1982; Grewe et ai, 1982). It has now been shown that atopic 
keratinocytes also express low densities of {32-adrenoceptors and 
that these receptors have a 6-fold decrease in the kDa for specitic 
antagonist ligand binding. 
Analysis of the {32-adrenoceptor gene in atopic eczema revealed 
a single base substitution in codon 1618GCC to GAC representing a 
change of Ala 119 to Asp. This mutation is expressed on the second 
tum of trans-membrane helix III and is only 6.7 A away from the 
known agonist/antagonist binding site at ASp"3 and can alter both 
the structure and function of the {32-adrenoceptor, leading to a very 
narrow range for the catecholamine/adrenoceptor interaction com­
pared to controls.2 One consequence of this metabolic defect 
would be a lack of homeostasis in the catecholamine biosynthetic 
pathway with increased norepinephrine levels in plasma together 
with increased MAO-A activities (Schallreuter ct aI, in press). This 
catecholamine/ {32-adrenoceptor dysregulation has been confirmed 
in keratinocyte cell cultures from atopic eczema families in which 
obligate heterozygotes present 50'Yo of the homeostatic signal 
transduction range between homozygotes and healthy controls. It is 
noteworthy that the {32-adrenoceptor gene is located on the 
chromosome 5 (q31_q32). This region has also been implicated in a 
linkage analysis of 303 patients with astlm1a, another component of 
the atopic triad (Postma et ai, 1995). 
2 Schallreuter KU, Wei Y, Pittelkow MR, Swanson NN, Korner C. 
Lindsey NJ, Wood JM, Gardner MLG: Atopic eczema can be associated 
with a mutation in the beta-2-adrcnoceptor gene. J Illves! Derma/of 106:902, 
1996 (abstr 582). 
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CLOSING COMMENTS 
At the present time, our understanding of the adrenergic systems in 
the human epidermis is focused on two important control points: (i) 
the availability of the essential amino acid L-phenylalanine, and (ii) 
the de 1101'0 synthesis and recycling of 6-BH4• These two factors 
appear to control the supply of L-tyrosine for melanogenesis in 
melanocytes and catecholamine synthesis/homeostasis in keratino­
cytes. Furthermore, this system is one important component in the 
control of the calcium gradient vis a vis differentiation and the cell 
cycle. The presence of the adrenergic signal transduction system, 
however, forms only one part of the neuronal network in the 
epidermis. The recent discovery of the cholinergic pathways by 
Grando et al (1995, 1996) suggests that cross-interactions must 
occur between the adrenergic and cholinergic signal transduction 
pathways as observed in other tissues. This important synergism in 
the human epidermis could play a major part in the establishment of 
the described calcium gradient from basal keratinocytes to the 
stratum granulosum. Unfortunately, at the present time, a complete 
understanding of tills scenario is still lacking, but certainly these 
systems must play an important role in various skin disorders. 
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